Nanomedicine for Targeted Drug Delivery Market

Nanomedicine for Targeted Drug Delivery Market Overview

The global nanomedicine for targeted drug delivery market size, valued at USD 87 billion in 2024, is projected to reach USD 98 billion in 2025 and USD 260 billion by 2035, representing a CAGR of 10.2% during the forecast period.

Nanomedicine for Targeted Drug Delivery Market: In Summary

• The nanomedicine for targeted drug delivery market is experiencing significant growth, driven by the increasing demand for advanced drug delivery systems that improve efficacy and reduce side effects by delivering drugs directly to the target site. As a result, this market is expected to grow at a CAGR of 10.2% during the forecast period.
• In terms of type of product, the liposomes segment holds the largest market share due to their biocompatibility, ability to surpass blood-brain-barrier and widespread use in cancer therapy. However, polymeric nanoparticles are projected to show the highest CAGR, driven by advancements that enhance their stability and targeting capabilities.
• The oncology disorders segment will remain dominant in the future as nanomedicine is highly effective in delivering drugs directly to tumor sites. Further, the neurological disorders segment is expected to grow at the highest CAGR, as nanocarriers, such as liposomes, can cross the challenging blood-brain barrier to treat disorders.
• In terms of application area, drug delivery segment holds the largest market share, driven by the growing use of nanoparticles and liposomes for targeted delivery.
• North America dominates the market with nearly a 45% share due to the advanced healthcare infrastructure and significant R&D investments for the development of nanotechnology. However, the Asia-Pacific region is expected to exhibit the highest CAGR, fueled by increasing healthcare investments and government support for nanotechnology research.
• The key players, such as Pfizer (US), Novartis (Switzerland), and Jazz Pharmaceuticals (Ireland) are undertaking strategic initiatives to support the development of nanomedicine for targeted drug delivery.
• The future of nanomedicine for targeted drug delivery lies in continued innovation, particularly in combining therapeutic and diagnostic functions into single platforms (theranostics nanomedicine). The development of combination drugs and the application of AI will enhance therapeutic outcomes and open up new avenues for treatment.

Nanomedicine for Targeted Drug Delivery Market Introduction

Nanomedicine is experiencing significant growth, driven by the growing demand for target specific drug delivery system to enhance efficacy by delivering drug at the right area. It involves the use of nanomaterials, such as protein-based nanoparticles, liposomes, and dendrimers at the nanoscale (1-1000 nm) for delivering drugs at targeted sites. Moreover, the nanoparticles can be engineered to deliver drugs directly to diseased tissues or cells, thereby reduce the chances of damage to healthy cells.

Notably, the demand for nanomedicine for targeted drug delivery has increased due to the rising concern of chronic conditions, neurological conditions, and cancer. Notably, cancer has been a major cause of concern, affecting millions of individuals worldwide. As per the report of National Institute of Health, in 2025, around 2,04,910 new cancer cases are projected to occur in the US. It is important to highlight here that the traditional drug delivery systems for cancer have certain limitations, such as non-specific targeting, poor bioavailability, and significant adverse effects. Due to the smaller size and unique design, nanomedicine helps to overcome these challenges, thereby improve target efficacy and bioavailability of drugs.

Owing to its significances and rising demand for targeted drug delivery devices, several industrial players are undertaking initiatives to develop nanomedicine for drug delivery. For instance, in February 2025, IIT Madras (Indian Institute of Technology, Madras, India) researcher’s team have developed a patented nanotechnology for breast cancer treatment. Owing to the successful outcomes, this researcher team is seeking partnerships with pharmaceutical industries for clinical trials and commercialization. As more research organizations and industrial players continue to accelerate research on nanoparticle formulation for drug delivery, it is expected that nanomedicine for targeted drug delivery market will grow steadily in the upcoming years.

Nanomedicine for Targeted Drug Delivery Market: Report Attributes

One of the key objectives of the nanomedicine for targeted drug delivery market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.

The global nanomedicine for targeted drug delivery market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product, therapeutic area, route of administration, application area, end user, geographical regions, and leading players.

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry's evolution.

Recent Developments in Nanomedicine for Targeted Drug Delivery Market

Several recent developments in the field of nanomedicine for targeted drug delivery industry have occurred, and we have outlined some of these below:

• In May 2025, a team of researchers from India in collaboration with scientists from the UAE and Saudi Arabia developed a novel drug delivery system for colon cancer by using cross-linked nanoparticles derived from mastic gum, a natural resin.

• In May 2025, a team of researchers from the Brown University successfully developed a latest nanotechnology-based approach to treat fungal infection, specifically those that occurred due to drug-resistant Candida species.

Nanomedicine for Targeted Drug Delivery Market Segmentation Insights

The market report presents an in-depth analysis of nanoparticle drug delivery systems providers who are currently active across various segments of the industry as mentioned below:

Nanomedicine for Targeted Drug Delivery Market: Market Segmentation

Industry Experts on Nanomedicine for Targeted Drug Delivery Market

Leading experts across academia, industry, and regulatory agencies provide compelling perspectives on nanomedicine's future trajectory.

In an interview, Dr. Mansoor Amiji (Distinguished Professor and Director of the Nanomedicine Innovation Center at Northeast) stated that, the extensively researched nanoparticles and his lab's mission to develop clinically and commercially translatable drug delivery systems for patient benefit, focusing on creating commercially and clinically viable technologies through collaboration with companies and stakeholders.” The future of nanomedicine seems promising owing to the ongoing research.

Nanomedicine for Targeted Drug Delivery Market Share Insights

Market Share by Type of Product: Are Liposomes or Nanoparticles Capturing Larger Market Share in Drug Delivery?

• Based on the type of product, the global market is segmented into liposomes, polymeric nanoparticles, dendrimers, micelles, solid lipid nanoparticles, mesoporous nanoparticles, and other products. According to the nanomedicine targeted drug delivery market forecast, the liposomes segment holds the highest share of the market. This is due to higher biocompatibility and clinical applications in cancer therapeutics and neurological disorders. Its amphiphilic characteristics enable them to carry hydrophobic, hydrophilic, and lipophilic drugs for flexible drug delivery at targeted sites.
• Notably, the polymeric nanoparticles segment is showing a robust growth potential, anticipating registering higher CAGR during the forecast period. The recent advancements in nanoparticles have significantly improved stability, enhanced targeting capabilities, and ensure controlled drug release. These advancements are likely to propel its demand in the future as advanced drug delivery system.

Market Share by Route of Administration: Will Intravenous Segment Dominate the Market in the Future?

• Based on the route of administration, the global market is segmented into intravenous, oral, intranasal, intrathecal, and other route of administrations. According to the nanomedicine targeted drug delivery market report, the intravenous segment accounts for the highest share of the market and the trend is likely to remain unchanged in the future.
• It is important to highlight here that nanomedicine for targeted drug delivery market growth for intranasal route of administration is highest amongst other segments during the forecast period. This growth is likely to be the result of growing innovations, such as dry powder inhalers for targeted respiratory treatments.

Market Share by End User: How Nanotechnology in Pharmaceutical Industry is Gaining Traction in the Future?

• According to nanomedicine for targeted drug delivery market forecast the global market is segmented based on end user into hospitals and clinics, research and academic institutes, diagnostic laboratories, pharmaceutical and biotechnology companies, and other end users. It is worth noting that the hospitals and clinics segment is securing maximum share of the targeted nanomedicine market growth. This can be attributed to the increasing demand for efficient and target specific target therapeutic delivery solutions. Nanomedicine offers specific benefits, such as minimal toxicity, high target specificity and high biocompatibility are increasing its adoption across hospitals and clinics to treat wide range of indications.
• Notably, the pharmaceutical and biotechnology companies segment is likely to grow at the fastest CAGR during the forecast period. It is worth noting that the innovations of nanotechnology in pharmaceutical industry for combined therapeutics and diagnostics is likely to propel the market growth of this segment.

Nanomedicine for Targeted Drug Delivery Market: Report Deliverables

Nanomedicine for Targeted Drug Delivery Market Key Takeaways

The "Nanomedicine for Targeted Drug Delivery Market Report: Industry Trends and Global Forecasts, till 2035" market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, and future opportunities for market players. The market research report lays emphasis on the nanomedicine for targeted drug delivery that is being developed. Key takeaways of the market report are briefly discussed below.

Competitive Landscape: Is Market for Nanomedicine for Targeted Drug Delivery Competitive?

The market landscape of nanomedicine for targeted drug delivery features a wide array of well-established pharmaceutical companies and new entrants. Leading market players, such as Pfizer (US), Novartis (Switzerland), and Johnson & Johnson (US) are undertaking several research initiatives to develop nanomedicine for targeted drug delivery. However, the primary focus of industrial players will be on collaborations and innovations to expand usage of nanomedicine applications across diverse therapeutic applications. As more market players proliferate in the market, it is expected that the market will grow at a higher CAGR in the future.

Market Size Analysis: Why Combination Nanomedicine Approaches Show Enhanced Therapeutic Outcomes In Oncology Applications?

In 2025, the global nanomedicine drug delivery market size is valued at USD 98 billion and poised to reach USD 260 billion by 2035. The current focus of industrial players is on combination nanomedicine approach to enhance therapeutic outcomes in oncology applications. Notably, cancerous cells can develop resistance to a particular drug with time, which creates challenges in treating patients. In order to overcome these challenges, researchers are aiming for combination approach which involves co-delivery of medicine through nanoparticles as they can encapsulate the therapeutic agents. This combinational approach further reflects market growth in the upcoming years.

Nanomedicine for Target Drug Delivery Market Trends

The biodegradable nanocarriers market is experiencing an upward trajectory driven by the ongoing trends listed below:

Integration of Artificial Intelligence: How is AI Integration Impacting Nanomedicine Drug Delivery Market Growth?

The integration of artificial intelligence in nanotechnology holds a promising future. This AI integration helps in understanding the nanomaterial-biological system interaction. This information collected through predictive modeling helps to optimize nanoparticles drugs formulation. Moreover, the advanced machine learning models, such as QSAR and MTK-QSBER improve prediction of nanoparticle cytotoxicity and in vivo behavior, supporting safer drug delivery system design and reducing costly late-stage failures.

Expanding Therapeutic Applications Beyond Oncology

The market for nanomedicine for targeted drug delivery is further propelled by the expanding therapeutic applications beyond oncological disorders. It is worth noting that, the market players are exploring the application of nanoparticles and theranostic nanomedicine platforms to target wide range of therapeutic applications, such as infectious diseases, neurological disorders, and regenerative medicine applications. In addition, the gene therapy applications also represent significant growth opportunities for nucleic acid delivery to treat patients.

Nanomedicine for Targeted Drug Delivery Market Report Coverage

• An Infographic Executive Summary
• Regulatory Scenario
• Comprehensive Database of Leading Players
• Competitive Landscape
• Company Competitiveness Analysis
• Startup Ecosystem in the Nanomedicine for Targeted Drug Delivery Market
• Company Profiles
• Porter’s Five Forces Analysis
• Patent Analysis
• Partnerships and Collaborations
• Grant Analysis
• Funding and Investment Analysis
• Clinical Trial Analysis
• Market Forecast and Opportunity Analysis
• Adjacent Market Analysis
• Key Winning Strategies
• SWOT Analysis

Glossary

• Bioavailability: The extent and rate at which the active pharmaceutical ingredient is absorbed from a drug formulation and becomes available at the site of action for therapeutic effect.
• Biocompatibility: The ability of a nanomaterial or nanomedicine formulation to perform its intended function without eliciting adverse biological responses or toxic effects in the host organism.
• Blood-Brain Barrier (BBB): A selective barrier formed by endothelial cells that prevents most substances from entering the brain from the bloodstream, presenting a significant challenge for drug delivery to the central nervous system that nanomedicine seeks to overcome.
• Dendrimers: It is a tree-like macromolecular structure with well-defined architecture that serve as drug delivery vehicles, offering multiple attachment points for therapeutic agents and targeting ligands.
• Nanomedicine: The application of nanotechnology in healthcare for the diagnosis, treatment, prevention, and monitoring of diseases, utilizing materials and devices at the nanoscale (1-100 nanometers).

From the Author’s Desk

Author’s View on Nanomedicine for Targeted Drug Delivery Market

Nanomedicine for targeted drug delivery offer a broad scope driven by the growing shift towards personalization and target specific drugs demand. Currently, several research studies and clinical trials are undergoing which reflect positive outcomes in the upcoming years. Moreover, the market players are also focusing on the development of combinational drugs and implementing AI technology to enhance the development of nanoparticles for targeted drug delivery. Several partnerships are undergoing which further indicate the promising future of this industry. Despite growing industry, challenges such as lack of standard guidelines, off-target effect and high expenses need to be addressed for widespread adoption.

Customization Opportunities

At Roots Analysis, we genuinely care about your success and understand that your business requirements are unique. While our market research reports provide valuable insights, we recognize that they might not cover every aspect you need to make well-informed strategic decisions. To account for that, we offer 15% free report customization tailored to your specific needs. Whether you require additional quantitative analysis, qualitative insights, or any other information related to the electric vehicles market, reach out to us today at support@rootsanalysis.com

Frequently Asked Questions